Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Clinical trial NCT00490529 · COMPLETED

Trial details

NCT number: NCT00490529
Sponsor: Ronald Levy
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell

Start date: 2009-08-01
Primary completion: 2017-12-14
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.